Valuation

HALOHalozyme Therapeutics Inc

StockNasdaq美國Health careEU retail: available

10/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	HALO	Sector median	vs median
P/E	32.1	28.8 · n=114	11% above
P/B	92.4	3.0 · n=196	2,966% above
P/S	8.0	3.7 · n=202	114% above
EV/EBIT	25.5	24.1 · n=103	6% above
Free-cash-flow yield	6.1%	2.8% · n=187	117% above
Dividend yield	0.00%	0.00% · n=215	—
Return on equity	173.7%	2.7% · n=193	6,435% above
Return on invested capital	21.7%	3.5% · n=176	511% above
Gross margin	82.4%	62.5% · n=152	32% above
Net debt / EBITDA	3.24	1.19 · n=108	172% above

Value factor: 60 of 100 within the peer group. Full score breakdown →

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	42.6	33.6	—	1.6%	0.6%	6/10
JNJJohnson & Johnson	29.1	7.2	—	3.6%	2.1%	8/10
ABBVAbbVie	79.9	—	33.5	3.6%	3.0%	5/10
MRKMerck	114.6	8.7	—	4.4%	2.3%	8/10
UNHUnitedHealth	25.1	3.4	18.6	6.7%	2.3%	9/10
TMOThermo Fisher Scientific	35.7	4.7	35.2	2.9%	0.3%	8/10
AMGNAmgen	26.3	19.7	24.0	4.4%	2.3%	6/10
GILDGILEAD	—	16.1	—	6.8%	2.1%	4/10
ABTAbbott	28.5	3.4	26.8	4.1%	3.0%	5/10
PFEPfizer	38.4	2.0	—	6.6%	5.9%	1/10

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 6月 2026 · filed 06 8月 2026

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.